Study on lipoprotein(a) and clot breakdown in heart disease
Part of Heart & circulation clinical trials.
This trial looks at how a type of fat in the blood called lipoprotein(a) and your body's ability to break down clots affect heart disease or heart valve disease. It is for people who are already taking certain cholesterol-lowering medicines or have severe aortic valve narrowing from calcium buildup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are already taking a PCSK9 inhibitor or inclisiran for cholesterol, OR have been diagnosed with moderate or severe aortic stenosis (a narrowed heart valve) on a CT scan
- You are willing to have blood samples taken for this study
- You do not have any medical condition that would make it unsafe, such as a bleeding disorder, or you are not taking part in another trial with an unapproved drug or device
- You agree to drink no more than 14 units of alcohol per week
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine called lepodisiran can shrink plaque in heart arteries for adults with high Lp(a) (a type of cholesterol linked to heart disease) who have had a heart event or are at serious risk. The trial uses CT scans to monitor changes in your arteries.
This study looks at how anti-platelet medicines like aspirin and clopidogrel work in people with hardened arteries (atherosclerosis) or peripheral artery disease (PAD). The goal is to understand how these drugs affect your body's clotting system.
This study looks at how blood platelets work in people who have high levels of lipoprotein(a), a type of fat in the blood that can increase heart risk. It tests if common blood thinners (aspirin and clopidogrel) work differently in these patients.
This study looks at levels of a type of cholesterol called Lp(a) in people with certain heart and blood vessel diseases. The goal is to understand how common high Lp(a) is in Russian adults with these conditions.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
This study looks at a type of fat in the blood called lipoprotein(a) and how it relates to calcium buildup in the heart arteries. Researchers are using CT scans to learn more about this connection in people who are at medium risk for heart problems.
Hear when a new Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.